Drug store chain operator CVS Caremark Corporation ( CVS ) on Tuesday posted better-than-expected third quarter earnings and lifted its full-year outlook.
The Woonsocket, RI-based company reported third quarter net income of $1.01 billion, or 80 cents per share, compared with $868 million, or 65 cents per share, in the year-ago period. Excluding special items, adjusted profit was 85 cents per share.
Revenue rose 13% from last year to $30.23 billion.
On average, Wall Street analysts expected a smaller profit of 83 cents per share, on lower revenue of $30.09 billion.
Looking ahead, CVS said it now expects full-year earnings to range from $3.38 to $3.41 per share, which would beat analysts' estimate of $3.36 per share for the year.
CVS Caremark shares rose $1.07, or +2.3%, in premarket trading Tuesday.
The Bottom Line
Shares of CVS Caremark ( CVS ) have a 1.39% dividend yield, based on last night's closing stock price of $46.63. The stock has technical support in the $42-$44 price area. The stock is trading near the all-time high price levels of $48-$49 a share.
CVS Caremark Corporation ( CVS ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.3 out of 5 stars.
Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Created by Dividend.com
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.